XTX Topco’s Pacira BioSciences PCRX Stock Holding History

XTX Topco’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.06M	Buy	91,114 +8,208	+10%	+$182K	0.04%	815
2025 Q4	$2.15M	Buy	+82,906	New	+$1.97M	0.06%	531
2025 Q2	–	Sell	-27,133	Closed	-$674K	–	2966
2025 Q1	$674K	Sell	27,133 -605	-2%	-$14.5K	0.03%	807
2024 Q4	$523K	Buy	+27,738	New	+$487K	0.04%	736
2024 Q3	–	Sell	-9,222	Closed	-$264K	–	2469
2024 Q2	$264K	Buy	9,222 +88	+1%	+$2.5K	0.02%	1047
2024 Q1	$267K	Buy	+9,134	New	+$281K	0.04%	950
2023 Q4	–	Sell	-13,588	Closed	-$417K	–	1983
2023 Q3	$417K	Buy	13,588 +5,557	+69%	+$200K	0.07%	505
2023 Q2	$322K	Buy	+8,031	New	+$332K	0.06%	669
2023 Q1	–	Sell	-17,522	Closed	-$677K	–	1564
2022 Q4	$677K	Buy	+17,522	New	+$852K	0.14%	187
2021 Q2	–	Sell	-2,886	Closed	-$202K	–	1025
2021 Q1	$202K	Buy	+2,886	New	+$206K	0.1%	497

Other funds holding PCRX

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return